Pay in 4 interest-free payments of $7.03 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
Stimulates gonadotropin release from the pituitary, promoting LH and FSH production and downstream testosterone synthesis
Safety Considerations BPC-157 has an excellent safety profile
Phase 2 trial data showed weight loss of up to 24% at the highest dose, with phase 3 trials underway
People dealing with long-term health issues, insecurity, or fear are more likely to be drawn to a simple promise that feels empowering
/product/17/2075523/2.jpg?5399)
3.6 Industry funding disclosure Among the included randomized controlled trials (n = 93), 60 trials (64%) were fully or partially funded by pharmaceutical sponsors (e.g., Novo Nordisk, Eli Lilly)
The only tangentially relevant data comes from amphetamine studies where BPC-157 counteracted stereotypy and prevented behavioral sensitization, but amphetamine-induced stereotypy models psychosis and stimulant abuse, not ADHD symptoms
US$ 21.35
US$ 21.65
US$ 21.74
US$ 20.96
US$ 25.13
US$ 26.22
